40 patient data entries collated from reference Wong et al, 2008. Entry # | Mutations | allele 1 | allele 2 |
| Clinical representation | Symptoms | Age group | Patient age | Age of onset | Age of death | | 3 | G888S1
| L83P1
| Alpers is reported as diagnosis. Symptoms are cortical blindness, dementia, seizures, hepatopathy and hearing loss. | | | n/a | 10 | n/a | 29 | K1191R1
| P587L2 T251I
| Developmental delay/dementia, liver dysfunction, lactic acidosis, fatigue, pancreatitis, cyclic vomiting. | | | n/a | 1 | n/a | 49 | R853Q1
| T251I P587L2
| Developmental delay, dementia, lactic acidosis, microcephaly, FTT, hearing loss, abnormal MRI. | | | 0.2 | n/a | n/a | 81 | A467T2
| A467T2
| Onset 32 years with neuropathy, myopathy, SANDO, PEO. | | | n/a | 32 | n/a | 87 | A467T2
| A467T2
| Onset 23 years with ataxia, neuropathy, hearing loss, seizures, and VPA liver failure. From "Saneto et al, 2010": Sensory neuropathy, ataxia, seizure onset at 15 years, simple partial seizure and epilepsia partialis continua myoclonus, VPA treatment caused liver failure after 3 months, progressive encephalopathy, Sensorineural hearing loss, dysmetria, intention tremor, hypotonia | - | movement disorder (ataxia) | |
| | 23 | 15 | 23.5 | 96 | L886P1
| A467T2
| Onset 1 years with dementia, seizures, and liver failure. Alpers | | | 1 | 1 | n/a | 98 | T914P1
| A467T2
| Onset 2 years with dementia, seizures, and liver failure. Alpers | | | n/a | 2 | n/a | 121 | G737R5
| A467T2
| Onset 60 years with ataxia, neuropathy, myopathy, hearing loss, cerebellar atrophy, SANDO/SCAE, PEO. | - | movement disorder (ataxia) | |
| | n/a | 60 | n/a | 128 | R1138C1
| A467T2
| Onset 48 years with neuropathy, myopathy, SANDO, lactic acidosis PEO. | | | n/a | 48 | n/a | 133 | R1128H1
| G517V2
| Onset at 1 years with microcephaly, developmental delay/ dementia, and liver dysfunction. Authors reported as undiagnosed. | | | n/a | 1 | n/a | 134 | D1196N1
| G517V2
| Onset at 1 years with myopathy, developmental delay/ dementia, RRF, and elevated CK. Authors reported as undiagnosed. | | | n/a | 1 | n/a | 154 | R943C1 E1143G
| G737R5
| Onset at age 3 with dementia,lactic acidosis, renal tubulopathy, dysmorphic features, cataract, short stature, myopathy. | | | n/a | 3 | n/a | 168 | W748S5 E1143G
| W748S5 E1143G
| Onset 33 years with neuropathy, myopathy, SANDO, lactic acidosis, PEO. | | | n/a | 33 | n/a | 191 | R964C1
| A862T1
| Onset 17 years with ataxia, exercise intolerance, cerbellar atrophy, SCAE, seizures, dementia. | - | movement disorder (ataxia) | |
| | n/a | 17 | n/a | 208 | | Y955C1
| Onset 0.1 years with dementia, liver dysfunction, lactic acidosis, hearing loss, failure to thrive, generalized ETC complex deficiency. | | | n/a | 0.1 | n/a | 219 | | I1079L3
| Onset 66 years with PEO, hearing loss, ptosis. | | | n/a | 66 | n/a | 222 | | S1095R3
| Onset 46 years with PEO, muscle weakness, optic atrophy, hearing loss, ptosis. | | | n/a | 46 | n/a | 232 | | G1205A
| Onset at 0.8 years with retinitis pigmentosa, hearing loss, failure to thrive, seizures, and dementia. | | | n/a | 0.8 | n/a | 623 | Splice site mutation: c.2157+5_+6gc>ag
| A467T2
| Alpers, stroke, hypotonia, Dementia, developmental delay, seizures. | | | n/a | 1 | n/a | 624 | Q1236H Frameshift: p.T849H(insC)fs868X
| A467T2
| Alpers, chorea, microcephaly, leukodystrophy, Seizures, Dementia, developmental delay. | | | n/a | 1.5 | n/a | 625 | R627Q5 G11D
| R852C1
| Seizures, PEO, Ataxia Neuropathy Spectrum, Stroke, chorea, ataxia, ptosis, retinitis pigmentosa, liver transplant | - | movement disorder (ataxia) | |
| | 19 | 15 | n/a | 626 | Splice site mutation: C.2480+1G>A
| E1143G W748S5
| Muscle weakness, respiratory failure, Alpers, Lactic acidosis, Seizures, Demential , developmental delay | | | n/a | 4 | n/a | 627 | Q497H2 W748S5 E1143G
| A467T2
| Hearing loss, Ataxia Neuropathy Spectrum, Seizures, dementia, developmental delay | - | movement disorder (ataxia) | |
| | n/a | 17 | n/a | 628 | G11D R627Q5
| R852C1
| Ataxia Neuropathy Spectrum, Seizures, PEO, lactic acidosis, stroke, chorea, ataxia, ptosis, retinitis pigmentosa, liver transplans | - | movement disorder (ataxia) | |
| | n/a | 15 | n/a | 629 | G848S1
| A467T2
| Developmental delay, dementia, seizures, Alpers, Ataxia | - | movement disorder (ataxia) | |
| | n/a | 2 | n/a | 630 | G848S1
| A467T2
| Developmental delay, dementia, seizures, Alpers, Lactic acidosis, Stroke | | | n/a | 2 | n/a | 631 | G848S1
| A467T2
| Developmental delay, dementia, seizures, Alpers, Lactic acidosis, Cortical athrophy, hypoglycemia | | | n/a | 1.5 | n/a | 632 | G848S1
| A467T2
| Developmental delay, dementia, seizures, Alpers, Stroke, ataxia, exercise intolerance | - | movement disorder (ataxia) | |
| | n/a | 9 | n/a | 633 | G848S1
| A467T2
| Developmental delay, dementia, seizures, Alpers, hypotonia, failure to thrive | | | n/a | 0.8 | n/a | 634 | G848S1
| A467T2
| Developmental delay, dementia, seizures, Alpers | | | n/a | 2 | n/a | 635 | Frameshift: p.L424GfsX28
| A467T2
| Developmental delay, dementia, seizures, Alpers, Family history of acute liver failure | | | n/a | 1 | n/a | 636 | Nonsense mutation: Q68X
| A467T2
| Developmental delay, dementia, seizures, Alpers, Ptosis, ataxia, visual hallucinations | - | movement disorder (ataxia) | |
| | n/a | 3 | n/a | 637 | Nonsense mutation: Q715X
| A467T2
| Developmental delay, dementia, seizures, Alpers | | | n/a | 4 | n/a | 638 | T914P1
| A467T2
| Developmental delay, dementia, seizures, Alpers | | | n/a | 2 | n/a | 639 | G848S1
| P587L2 T251I
| Alpers | | | n/a | 0.5 | n/a | 640 | R1096C3 Q1236H
| R1096C3 Q1236H
| developmental delay, dementia, seizures, Alpers, Family history of Alpers syndrome. | | | n/a | 1 | n/a | 641 | G848S1
| Q497H2 W748S5 E1143G
| developmental delay, dementia, seizures, Alpers, Family history of Alpers syndrome. | | | n/a | 1 | n/a | 642 | | S305R3
| developmental delay, dementia, lactic acidosis, alpers | | | n/a | 1 | n/a | 643 | | V855A1
| Muscle weakness, PEO | | | n/a | 9 | n/a | 644 | | R617C2
| Lactic acidosis, Muscle weakness, exercise intolerance, hearing loss, arhytthmia | | | n/a | 39 | n/a |
1-5 pathogenic cluster assignment of mutations. Mutations displayed without a superscript number are outside of the assigned pathogenic clusters. See cluster definitions for details.
|